Completed PHASE2 INTERVENTIONAL 2-arm NCT03064438

Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea

A RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, PROOF-OF CONCEPT STUDY OF THE SAFETY AND EFFICACY OF ACU-D1 OINTMENT IN SUBJECTS WITH ACNE ROSACEA

Sponsor: Accuitis, Inc.

Conditions Acne Rosacea

Interventions ACCU-D1 Vehicle

Updated 8 times since 2017 Last updated: Aug 17, 2021 Started: Nov 28, 2017 Primary completion: Jun 5, 2018 Completion: Jun 18, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acne Rosacea, this trial is completed. The trial is conducted by Accuitis, Inc. and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jan 2021 — Sep 2021 [monthly]

Unknown Status PHASE2
May 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — May 2020 [monthly]

Active Not Recruiting PHASE2
May 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

Status: Not Yet Recruiting → Active Not Recruiting
Mar 2017 — May 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Accuitis, Inc.

Data source: Accuitis, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States
• Louisville, United States